A supplement to Family Practice News and Internal Medicine News.
Letter From Guest Editor
Larry Culpepper, MD, MPH
Chief of Family Medicine
Boston Medical Center
Professor and Chairman of Family Medicine
Boston University School of Medicine
Dr. Culpepper has disclosed that he is a consultant to Eli Lilly and Company, Forest Laboratories, Inc., Neurocrine Biosciences, Inc., Pfizer Inc. and Wyeth. He is also on the speaker's bureau for Forest, Pfizer, and Wyeth.
Special Populations in Depression: Managing Care for Patients With Depression and Comorbid Health Problems
Larry Culpepper, MD
• Postherpetic Neuralgia
• Diabetes and Pain
Bill McCarberg, MD
Founder. Chronic Pain Management Program
Dr. McCarberg has disclosed that he is on the speaker's bureau for Alpharma Inc., Cephalon, Inc., Eli Lilly and Company, Endo Pharmaceuticals, Merck & Co., Inc., Ortho-McNeil Pharmaceutical, Inc., Pfizer Inc., and Pricara.
Practical Bits: Quick and Practical Diagnostic Tools
Clinical Approaches to Patient Concerns About Memory Loss
Richard J. Caselli, MD
Chair, Department of Neurology
Mayo Clinical Scottsdale (Arizona)
Professor of Neurology
Mayo Clinic College of Medicine
Dr. Caselli disclosed that he has received funding for clinical grants from Arizona Alzheimer's Consortium.
Social and Emotional Costs of Learning Disabilities
Carl C. Bell, MD
Chief Executive Officer and President
Community Mental Health Council Inc.
Director, Public and Community Psychiatry
University of Illinois, Chicago, Ill.